Project Grant R01HL173998
Award Date
12/12/24
Completion Date
11/30/28
Dollars Obligated
$672K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Newark, NJ 07107, USA
Similar Awards
The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), has awarded a $742,395 Project Grant (CFDA 93.837 - Cardiovascular Diseases Research) to Case Western Reserve University to develop and validate a machine learning-based risk prediction model for heart failure using coronary artery calcium scans. The project aims to leverage the large patient populations from the University Hospitals CLARIFY and Houston Methodist HeartScan programs, as well as...
This Project Grant award of $1,139,398.66 from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports research to develop computational models that can predict the risk of heart failure following a myocardial infarction (heart attack). The project aims to refine and validate subject-specific models of cardiac growth and remodeling processes, and to quantify the propensity for adverse remodeling and identify risk factors for...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research federal grant program (CFDA 93.837), is for a research project titled "Artificial Intelligence Imaging Biomarkers of Longitudinal Cardiovascular Stress." The $1,526,628 award, effective from December 12, 2024 to January 31, 2025, will fund the development and validation of artificial intelligence (AI) models to predict biological cardiovascular age from...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $666,609 to North Carolina State University to develop quantitative lung ultrasound (LQUS) methods for monitoring pulmonary edema due to heart failure and idiopathic pulmonary fibrosis. The goal is to create real-time, non-invasive LQUS biomarkers that can assess the severity of these lung conditions with high sensitivity and specificity,...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $750,406 to the University of Cincinnati to develop novel 4D parametric image reconstruction techniques for dynamic 82Rb PET myocardial perfusion imaging. The goal is to significantly reduce measurement uncertainty and improve the diagnostic accuracy and reliability of this imaging approach for evaluating ischemic heart disease...
This federal Project Grant award of $777,674.00 from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research federal grant program (CFDA 93.837), aims to build the largest echocardiography registry in the world and apply advanced causal inference methods to measure the effectiveness of guideline-directed medical therapies for patients with heart failure and mid-range ejection fraction. The award will fund the development of natural language processing...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $753,813 Project Grant (CFDA 93.837 - Cardiovascular Diseases Research) to Yale University to conduct research on predicting cardiovascular outcomes through machine learning analysis of cardiac MRI and genomics data. The research aims to develop an innovative cardiovascular risk assessment tool that can accurately identify individuals with clonal hematopoiesis of indeterminate potential (CHIP) and predict their risk of developing...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research Program (CFDA 93.837), provides $704,611 to The Trustees of Columbia University in the City of New York to develop and validate an AI-powered model, named EchoNext, that can accurately detect undiagnosed structural heart disease from electrocardiogram (ECG) data. The overarching goal is to enable effective and equitable diagnosis of structural heart...
This federal Project Grant award, provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), supports the development of AUTOCHAMBER - an FDA-designated breakthrough AI tool designed to detect cardiac abnormalities, including enlarged chambers and left ventricular hypertrophy, from existing chest CT scans. The $294,023 award to Heartlung Corporation will be used to validate AUTOCHAMBER's performance in predicting atrial...
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $608,944 Project Grant under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" program (CFDA 93.286) to Brigham & Women's Hospital Inc. The project aims to develop an AI-assisted strategy for monitoring pulmonary congestion in acute heart failure patients in emergency settings. Specifically, the project will automate lung ultrasound congestion scoring using...